Neurofibromatoses

The Causes of Epilepsy: Common and Uncommon Causes in Adults and Children

Volumn , Issue , 2011, Pages 183-188

  Ferner, Rosalie E ^a   Jackson, Margaret J ^b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880035187     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511921001.027     Document Type: Chapter

References (36)

1. Baser ME, Friedman JM, Wallace AJ, et al. (2002) Evaluation of clinical diagnostic criteria for neurofibromatosis 2. Neurology 59:1759-65.
2. Boyd C, Smith MJ, Kluwe L, et al. (2008) Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis. Clin Genet 74:358-66.
3. Brems H, Chmara M, Sahbatou M, et al. (2007) Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet 39:1120-6.
4. Daston MM, Scrable H, Nordlund M, et al. (1992) The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes. Neuron 8:415-28.
5. Evans DG, Huson SM, Donnai D, et al. (1992) A clinical study of type 2 neurofibromatosis. Q J Med 84:603-18.
6. Evans DG, Baser ME, O’Reilly B, et al. (2005) Management of the patient and family with neurofibromatosis 2: a consensus conference statement. Br J Neurosurg 19:5-12.
7. Fedi M, Mitchell A, Kalnins RM, et al. (2004) Glioneuronal tumors in neurofibromatosis type 1: MRI-pathological study. J Clin Neurosci 11:745-7.
8. Ferner RE (2007) Neurofibromatosis 1 and neurofibromatosis 2: a twenty-first century perspective. Lancet Neurol 6:340-51.
9. Ferner RE, Jan W (2001) Epilepsy in neurofibromatosis. J Neurol Sci 819:S280.
10. Ferner RE, Chaudhuri R, Bingham J, Cox T, Hughes RA (1993) MRI in neurofibromatosis 1: the nature and evolution of increased intensity T2-weighted lesions and their relationship to intellectual impairment. J Neurol Neurosurg Psychiatry 56:492-5.
11. Ferner RE, Hughes RA, Weinman J (1996) Intellectual impairment in neurofibromatosis 1. J Neurol Sci 138:125-33.
12. Ferner RE, Huson SM, Thomas N, et al. (2007) Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 44:81-8.
13. Hurtado B, Koepp MJ, Sander JW, Thompson PJ (2006) The impact of levetiracetam on challenging behavior. Epilepsy Behav 8:588-92.
14. Huson SM, Harper PS, Compston DA (1988) Von Recklinghausen neurofibromatosis: A clinical and population study in south-east Wales. Brain 111:1355-81.
15. Hyman SL, Gill DS, Shores EA, Steinberg A, North KN (2007) T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning. J Neurol Neurosurg Psychiatry 78:1088-91.
16. Johannessen CM, Reczek EE, James MF, et al. (2005) The NF1 tumor suppressor critically regulates TSC2 and mTOR. Proc Natl Acad Sci USA 102:8573-8.
17. Korf BR, Carrazana E, Holmes GL (1993) Patterns of seizures observed in association with neurofibromatosis 1. Epilepsia 34:616-20.
18. Krab LC, De Goede-Bolder A, Aarsen FK, (2008) Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial. J AmMed Ass 300:287-94.
19. Kulkantrakorn K, Geller TJ (1998) Seizures in neurofibromatosis 1. Pediatr Neurol 19:347-50.
20. Maccollin M, Chiocca EA, Evans DG, et al. (2005) Diagnostic criteria for schwannomatosis. Neurology 64:1838-45.
21. Marson AG, Al-Kharusi AM, Alwaidh M, et al. (2007) The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 369:1000-15.
22. Mayfrank L, Mohadjer M, Wullich B (1990) Intracranial calcified deposits in neurofibromatosis type 2: a CT study of 11 cases. Neuroradiology 32:33-7.
23. McKeever K, Shepherd CW, Crawford H, Morrison PJ (2008) An epidemiological, clinical and genetic survey of neurofibromatosis type 1 in children under sixteen years of age. Ulster Med J 77:160-3.
24. Motte J, Billard C, Fejerman N, et al. (1993) Neurofibromatosis type 1 and West syndrome: a relatively benign association. Epilepsia 34:723-6.
25. National Institutes of Health Consensus Development Conference (1988) Neurofibromatosis: Conference statement. Arch Neurol 45:575-8.
26. Omeis I, Hillard VH, Braun A, et al. (2006) Meningioangiomatosis associated with neurofibromatosis: report of two cases in a single family and review of the literature. Surg Neurol 65:595-603.
27. Rosman NP, Pearce J (1967) The brain in multiple neurofibromatosis (von Recklinghausen’s disease): a suggested neuropathological basis for the associated mental defect. Brain 90:829-38.
28. Ruggieri M, Huson SM (2001) The clinical and diagnostic implications of mosaicism in the neurofibromatoses. Neurology 56:1433-43.
29. Ruggieri M, Iannetti P, Clementi M, et al. (2009) Neurofibromatosis type 1 and infantile spasms. Childs Nerv Syst 25:211-16.
30. Szudek J, Birch P, Riccardi VM, Evans DG, Friedman JM (2000) Associations of clinical features in neurofibromatosis 1 (NF1). Genet Epidemiol 19:429-39.
31. Trofatter JA, MacCollin MM, Rutter JL, et al. (1993) A novel moesin-, ezrin-, radixinlike gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72:791-800.
32. Viskochil D, Cawthon R, O’Connell P, (1991) The gene encoding the oligodendrocyte-myelin glycoprotein is embedded within the neurofibromatosis type 1 gene. Mol Cell Biol 11:906-12.
33. Vivarelli R, Grosso S, Calabrese F, (2003) Epilepsy in neurofibromatosis 1. J Child Neurol 18:338-42.
34. Wiestler OD, Von Siebenthal K, Schmitt HP, Feiden W, Kleihues P (1989) Distribution and immunoreactivity of cerebral microhamartomas in bilateral acoustic neurofibromatosis (neurofibromatosis 2). Acta Neuropathol 79:137-43.
35. Xu GF, O’Connell P, Viskochil D, et al. (1990) The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62:599-608.
36. Zhu Y, Romero MI, Ghosh P, et al. (2001) Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev 15:859-76.